Valvular & structural heart disease

The role of cardiovascular magnetic resonance (CMR) in the timing of aortic valve interventions and risk stratification in aortic regurgitation: a systematic review and meta-analysis

Eur Heart J Cardiovasc ImagingPublished systematic review and meta-analysis

Pooled result · Clinic outcomes with an ARF > 33%Result — go to the resultPooled hazard ratio 4.12 95% CI 2.31–7.34

Authors' conclusion

CMR-derived ARF is strongly predictive of clinical outcomes. ARF > 33% is associated with significantly increased risk, warranting its integration into clinical decision-making frameworks.

Study context

Population
Patients with aortic regurgitation assessed with CMR-derived aortic regurgitation (AR) fraction (AR fraction (ARF))Eight studies included in the meta-analysis (12 met inclusion criteria, 1235 screened)
Participants
1,996 patients
Comparison
CMR-derived ARF > 33% and clinic outcomes
Outcome
Clinic outcomes with an ARF > 33%
Follow-up
Ranged from 2 to 5.1 years
Methodological detailsrandom-effects model, observational studies
  • Random-effects model
  • Observational studies

Pooled result

As reported in the abstract

Pooled hazard ratio

4.12

95% CI 2.31–7.34

P < 0.01

ARF > 33%
pooled HR 4.12 (95% CI 2.31–7.34); P < 0.01
Highest reported HR
24.59
Lowest reported HR
1.04

Further pooled results

ARF severity thresholds

Range
30 to 43%
Mean
33.7%

Original publication

The role of CMR in the timing of aortic valve interventions and risk stratification in aortic regurgitation: a systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging. Published 9 December 2025. doi:10.1093/ehjci/jeaf349

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.